Yseop
Information
Yseop leads in Generative AI for life sciences and pharmaceuticals, reshaping content automation with a human-centric AI platform.
Boosting productivity, ensuring quality, and slashing writing times across numerous clinical trials, Yseop serves as a "Copilot" for medical writers, enhancing efficiency and precision in generating vital reports for drug development. Addressing data security concerns, Yseop aims to streamline preclinical and clinical document automation, expediting life-saving drug approvals.
With over 150 clinical trials supported globally, including collaborations with industry giants like Eli Lilly, GSK, and Sanofi, Yseop received strategic investment from Novartis to further its mission. Recognized with accolades such as the Global Generative AI Award in Healthcare and Life Sciences and the Citeline Award for Best Use of AI in Clinical Trials, Yseop continues to innovate and drive industry transformation.